학술논문
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651
Document Type
Article
Author
Haddad, R.I.; Harrington, K.; Tahara, M.; Ferris, R.L.; Gillison, M.; Fayette, J.; Daste, A.; Koralewski, P.; Zurawski, B.; Taberna, M.; Saba, N.F.; Mak, M.; Kawecki, A.; Girotto, G.; Alvarez Avitia, M.A.; Even, C.; Toledo, J.G.R.; Guminski, A.; Müller-Richter, U.; Kiyota, N.; Roberts, M.; Khan, T.A.; Miller-Moslin, K.; Wei, L.; Argiris, A.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 April 2023, 41(12):2166-2180)
Subject
Language
English
ISSN
15277755
0732183X
0732183X